Ambulatory blood pressure monitoring‑detected 24‑hour blood pressure phenotypes in resistant hypertension

30 August 2026 (12:42 - 12:56)

Organised by:

Video

Sign in to view the resources

About the speaker

Associate Professor Grzegorz Bilo

University of Milan Bicocca, Milan (Italy)

5 More presentations in this session

Presentation thumbnail

Welcome, introduction, program framing, review of objectives

Professor G. Parati (Milan, IT)

Presentation thumbnail

Aldosterone and the 24-hour blood pressure burden

Professor R. Cifkova (Prague, CZ)

Presentation thumbnail

Targeting aldosterone: what ambulatory blood pressure monitoring studies tell us about aldosterone synthase inhibition

Professor G. Parati (Milan, IT)

Presentation thumbnail

From 24‑hour blood pressure to cardiorenal outcomes and future directions

Doctor P. Taub (La Jolla, US)

Presentation thumbnail

24-hour blood pressure burden: aldosterone, cardiorenal risk, and the next generation of blood pressure control - Q&A

Access the full session

Session thumbnail

24-hour blood pressure burden: aldosterone, cardiorenal risk, and the next generation of blood pressure control

The Event

Event poster

ESC Congress 2026

30 August 2026 12:42 CET

You may be interested in

Congress Presentation

Resistant hypertension must be defined by ambulatory blood pressure and pulse pressure is best predictor of new cardiovascular events

27 August 2021

Webinar

Management of blood pressure: selected case-based advice

11 December 2024

Congress Presentation

Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

21 May 2023

Congress Session

Blood pressure phenotypes and outcomes

31 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources